Research ArticleArticle
Antiasthmatic Activity of the Second-Generation Phosphodiesterase 4 (PDE4) Inhibitor SB 207499 (Ariflo) in the Guinea Pig
David C. Underwood, Steven Bochnowicz, Ruth R. Osborn, Charles J. Kotzer, Mark A. Luttmann, Douglas W.P. Hay, Peter D. Gorycki, Siegfried B. Christensen and Theodore J. Torphy
Journal of Pharmacology and Experimental Therapeutics December 1998, 287 (3) 988-995;
David C. Underwood
Steven Bochnowicz
Ruth R. Osborn
Charles J. Kotzer
Mark A. Luttmann
Douglas W.P. Hay
Peter D. Gorycki
Siegfried B. Christensen

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 287, Issue 3
1 Dec 1998
Research ArticleArticle
Antiasthmatic Activity of the Second-Generation Phosphodiesterase 4 (PDE4) Inhibitor SB 207499 (Ariflo) in the Guinea Pig
David C. Underwood, Steven Bochnowicz, Ruth R. Osborn, Charles J. Kotzer, Mark A. Luttmann, Douglas W.P. Hay, Peter D. Gorycki, Siegfried B. Christensen and Theodore J. Torphy
Journal of Pharmacology and Experimental Therapeutics December 1, 1998, 287 (3) 988-995;
Research ArticleArticle
Antiasthmatic Activity of the Second-Generation Phosphodiesterase 4 (PDE4) Inhibitor SB 207499 (Ariflo) in the Guinea Pig
David C. Underwood, Steven Bochnowicz, Ruth R. Osborn, Charles J. Kotzer, Mark A. Luttmann, Douglas W.P. Hay, Peter D. Gorycki, Siegfried B. Christensen and Theodore J. Torphy
Journal of Pharmacology and Experimental Therapeutics December 1, 1998, 287 (3) 988-995;